New research shows that fecal transplants may boost the effectiveness of cancer immunotherapy drugs called PD-1 inhibitors.

They’re taking the plunge. A small number of Canadian cancer patients are testing a pill that contains healthy bacteria from ...

Clostridioides difficile (C. difficile) infection (CDI) is a significant healthcare-associated infection, known for its high morbidity and mortality rates, especially in vulnerable populations. CDI ...

A synthetic microbiome therapy, tested in mice, protects against severe symptoms of a gut infection that is notoriously ...

A real-world study of patients with Clostridioides difficile infection (CDI) in Australia over 10 years shows that fecal ...

Scientists develop a synthetic microbiome therapy to fight C. difficile infections offering a safer, targeted alternative ...

A group of gut bacteria successfully hindered recurrent Clostridium difficile infection in mice, offering alternative ...

Since the FDA’s approval of the first fecal transplant pills in 2023, many experts are hopeful that adapting it and similar innovations could help treat particularly resistant cancers.

Patients with immunocompromised status and prior hospitalization for C diff were among those at increased risk of antibiotic ...